Comparison of Upper Extremity Exercise Capacity and ADL Between Subjects With Bronchiectasis and Healthy Controls

NCT05084547 | Completed

• 1 other identifier: GO 20/55
• Study Type: observational
• Target: 48
• Locations: 1 country
• Sites: 1

Brief Summary

Bronchiectasis is a chronic lung disease characterized by permanent dilatation and destruction, resulting from the destruction of elastic tissue and muscular components in the bronchial walls, due to infection or inflammation. The exercise tolerance, physical activity level, respiratory and peripheral muscle strength of patients with bronchiectasis are lower than those of healthy individuals. The decrease in exercise tolerance occurs while performing upper extremity activities as well as lower extremity tasks. Many studies have reported that upper extremity exercise capacity is reduced in chronic obstructive pulmonary disease (COPD), a disease similar to bronchiectasis, and that patients often experience significant dyspnea and fatigue during upper extremity tasks that are important for daily life. The mechanisms causing this situation may be neuromechanical dysfunction of the respiratory muscles (diaphragm and accessory respiratory muscles) (thoracoabdominal asynchrony) and changes in lung volume in activities involving the upper extremities. The disturbances in ventilatory mechanics in patients with COPD cause upper extremity exercise to be terminated at low workloads compared to healthy individuals. Upper extremity exercise has been defined as part of pulmonary rehabilitation. The determination of upper extremity exercise capacity may play a predictive role in maintaining and improving upper extremity and daily life activity level in patients with chronic lung disease. Six-minute Pegboard and Ring test (6PBRT) is used to evaluate extremity exercise capacity and upper extremity function and endurance. The 6PBRT score and upper extremity daily living activities show a clear relationship in patients with COPD, and it can be used to determine and improve the performance of daily living activities in pulmonary rehabilitation programs. Glittre Activities of Daily Living (Glittre ADL test) covers activities that are necessary for daily living and commonly used activities. The Glittre ADL test produces similar cardiorespiratory responses when compared with the six-minute walk test. In this study, unsupported upper extremity exercise capacity and upper extremity function/endurance and the performance of daily living activities will be compared in participants with bronchiectasis and compared with healthy individuals.

Conditions

Bronchiectasis

Outcome Measures

Primary Outcomes (7)

• Pulmonary function test - Forced vital capacity

  Pulmonary function test using a spirometer will be performed. Forced vital capacity will be recorded.

  1st day

• Pulmonary function test - Forced expiratory volume in one second

  Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second will be recorded.

  1st day

• Pulmonary function test - Forced expiratory volume in one second/Forced vital capacity

  Pulmonary function test using a spirometer will be performed. Forced expiratory volume in one second/Forced vital capacity in one second will be recorded.

  1st day

• Pulmonary function test - Peak expiratory flow

  Pulmonary function test using a spirometer will be performed. Peak expiratory flow will be recorded.

  1st day

• Pulmonary function test - Forced mid-expiratory flow (FEF25-75)

  Pulmonary function test using a spirometer will be performed. Forced mid-expiratory flow (FEF25-75) will be recorded.

  1st day

• Glittre Activities of Daily Living Test

  The test covers activities that are necessary for daily living and commonly used activities that are known to be difficult for patients with COPD.

  1st day

• Unsupported upper extremity exercise capacity

  Upper extremity exercise capacity will be evaluated using 6PBRT. During the test, the patient is asked to sit in front of a pegboard and move as many rings as possible from the two lower holes to the two upper holes, using both hands simultaneously, for six minutes. The number of rings carried during the six minutes constitutes the final score. Heart rate and oxygen saturation with pulse oximetry before and after the test, dyspnea, arm and general fatigue will be assessed.

  1st day

Study Arms (2)

Case

Subjects with Bronchiectasis

Other: No intervention

Control

Healthy Controls

Other: No intervention

Interventions

No intervention OTHER

No intervention

Case; Control

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Subjects with bronchiectasis and healthy controls

You may qualify if:

• Diagnosed with bronchiectasis and being clinically stable,
• Being 18 years old or older,
• Being able and willing to complete the informed consent process.

You may not qualify if:

• Individuals with bronchiectasis whose clinical condition is unstable,
• Individuals with bronchiectasis who have severe neuromuscular, musculoskeletal, and rheumatological problems,
• Being unable to cooperate,
• Not being willing to participate in the study
• The healthy controls will be composed of individuals who volunteered for the study without any known disease. Healthy individuals who did not volunteer to participate in the study will not be included.

Sponsors & Collaborators

• Hacettepe University: lead

Study Sites (1)

Hacettepe University

Ankara, 06100, Turkey (Türkiye)

Location

Related Publications (1)

• Cakmak A, Kocaaga E, Sonbahar-Ulu H, Inal-Ince D, Vardar-Yagli N, Calik-Kutukcu E, Saglam M, Coplu L. Upper Extremity Exercise Capacity and Activities of Daily Living in Individuals With Bronchiectasis Versus Healthy Controls. Phys Ther. 2023 Apr 4;103(4):pzad012. doi: 10.1093/ptj/pzad012.

  PMID: 37086209 DERIVED

MeSH Terms

Conditions

Bronchiectasis

Condition Hierarchy (Ancestors)

Bronchial Diseases; Respiratory Tract Diseases

Study Officials

• Aslihan Cakmak, MSc

  Hacettepe University

  STUDY DIRECTOR

• Deniz Inal-Ince, PhD

  Hacettepe University

  STUDY CHAIR

• Lutfi Coplu, MD

  Hacettepe University

  PRINCIPAL INVESTIGATOR

• Hazal Sonbahar-Ulu, PhD

  Akdeniz University

  PRINCIPAL INVESTIGATOR

• Ebru Calik-Kutukcu, PhD

  Hacettepe University

  PRINCIPAL INVESTIGATOR

• Naciye Vardar-Yagli, PhD

  Hacettepe University

  PRINCIPAL INVESTIGATOR

• Melda Saglam, PhD

  Hacettepe University

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: September 29, 2021
• First Posted: October 20, 2021
• Study Start: January 22, 2020
• Primary Completion: December 22, 2022
• Study Completion: December 22, 2022
• Last Updated: January 13, 2023

Record last verified: 2023-01

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)